Single-cell transcriptomics identifies prothymosin α restriction of HIV-1 in vivo

Host restriction factors play key roles in innate antiviral defense, but it remains poorly understood which of them restricts HIV-1 in vivo. Here, we used single-cell transcriptomic analysis to identify host factors associated with HIV-1 control during acute infection by correlating host gene expression with viral RNA abundance within individual cells. Wide sequencing of cells from one participant with the highest plasma viral load revealed that intracellular viral RNA transcription correlates inversely with expression of the gene PTMA, which encodes prothymosin α. This association was genome-wide significant (Padjusted < 0.05) and was validated in 28 additional participants from Thailand and the Americas with HIV-1 CRF01_AE and subtype B infections, respectively. Overexpression of prothymosin α in vitro confirmed that this cellular factor inhibits HIV-1 transcription and infectious virus production. Our results identify prothymosin α as a host factor that restricts HIV-1 infection in vivo, which has implications for viral transmission and cure strategies. Description Profiling of host and viral transcripts in the same single cells isolated during acute infection identified prothymosin α as restricting HIV-1. Editor’s summary Identifying factors that restrict human immunodeficiency virus (HIV)–1 replication in vivo may inform potential cure strategies for people living with HIV-1. Here, Geretz et al. analyzed transcripts from both the host and virus within the same single cells to identify host transcripts associated with lower HIV-1 RNA. Using samples from a person living with HIV-1, the authors identified prothymosin α as one such host restriction factor, which they validated in 28 additional participants. Further, overexpression of prothymosin α was sufficient to restrict HIV-1 replication in vitro. These data demonstrate that prothymosin α is a host restriction factor and suggest that it may represent a target for HIV-1 cure strategies. —Courtney Malo

[1]  J. Karn,et al.  Genomic profiling of HIV-1 integration in microglia cells links viral integration to the topologically associated domains. , 2023, Cell reports.

[2]  T. Holtz,et al.  HLA-B∗46 associates with rapid HIV disease progression in Asian cohorts and prominent differences in NK cell phenotype. , 2022, Cell host & microbe.

[3]  J. Ananworanich,et al.  HIV rapidly targets a diverse pool of CD4+ T cells to establish productive and latent infections , 2022, bioRxiv.

[4]  L. Montaner,et al.  Single-cell multiomics reveals persistence of HIV-1 in expanded cytotoxic T cell clones. , 2022, Immunity.

[5]  C. Lareau,et al.  Single-cell chromatin state analysis with Signac , 2021, Nature Methods.

[6]  F. Kirchhoff,et al.  An additional NF-κB site allows HIV-1 subtype C to evade restriction by nuclear PYHIN proteins , 2021, Cell reports.

[7]  Bertrand Z. Yeung,et al.  Scalable, multimodal profiling of chromatin accessibility, gene expression and protein levels in single cells , 2021, Nature Biotechnology.

[8]  J. Mascola,et al.  B cell engagement with HIV-1 founder virus envelope predicts development of broadly neutralizing antibodies. , 2021, Cell host & microbe.

[9]  F. Kirchhoff,et al.  Evolutionary conflicts and adverse effects of antiviral factors , 2021, eLife.

[10]  F. Kirchhoff,et al.  IFI16 knockdown in primary HIV-1 target cells , 2020, STAR protocols.

[11]  B. Walker,et al.  Evolution and Diversity of Immune Responses during Acute HIV Infection. , 2020, Immunity.

[12]  Raphael Gottardo,et al.  Integrated analysis of multimodal single-cell data , 2020, Cell.

[13]  Sara R. Selitsky,et al.  Epigenomic characterization of latent HIV infection identifies latency regulating transcription factors , 2020, bioRxiv.

[14]  H. Schuitemaker,et al.  Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption , 2020, Nature Medicine.

[15]  C2H2 Zinc Finger , 2020, Definitions.

[16]  J. P. Labuschagne,et al.  Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand , 2020, PLoS pathogens.

[17]  F. Kirchhoff,et al.  CpG Frequency in the 5′ Third of the env Gene Determines Sensitivity of Primary HIV-1 Strains to the Zinc-Finger Antiviral Protein , 2020, mBio.

[18]  Stephen A. Williams,et al.  Plasma protein patterns as comprehensive indicators of health , 2019, Nature Medicine.

[19]  Phillip A. Richmond,et al.  JASPAR 2020: update of the open-access database of transcription factor binding profiles , 2019, Nucleic Acids Res..

[20]  B. Walker,et al.  Augmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection , 2019, Science Translational Medicine.

[21]  Alireza Hadj Khodabakhshi,et al.  Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.

[22]  Jonathan R. McDaniel,et al.  Longitudinal Analysis Reveals Early Development of Three MPER‐Directed Neutralizing Antibody Lineages from an HIV‐1‐Infected Individual , 2019, Immunity.

[23]  R. Satija,et al.  Integrative single-cell analysis , 2019, Nature Reviews Genetics.

[24]  F. Kirchhoff,et al.  Key Viral Adaptations Preceding the AIDS Pandemic. , 2019, Cell host & microbe.

[25]  Bertrand Z. Yeung,et al.  Cell Hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics , 2018, Genome Biology.

[26]  Christoph Hafemeister,et al.  Comprehensive integration of single cell data , 2018, bioRxiv.

[27]  Andrew C. Adey,et al.  Cicero Predicts cis-Regulatory DNA Interactions from Single-Cell Chromatin Accessibility Data. , 2018, Molecular cell.

[28]  Jerome H. Kim,et al.  Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection , 2018, Nature Medicine.

[29]  J. Wong,et al.  HIV latency in isolated patient CD4+ T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing , 2018, Science Translational Medicine.

[30]  T. Hughes,et al.  The Human Transcription Factors , 2018, Cell.

[31]  H. Swerdlow,et al.  Large-scale simultaneous measurement of epitopes and transcriptomes in single cells , 2017, Nature Methods.

[32]  G. Learn,et al.  Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness , 2017, Proceedings of the National Academy of Sciences.

[33]  B. Walker,et al.  Single-Cell Characterization of Viral Translation-Competent Reservoirs in HIV-Infected Individuals. , 2016, Cell host & microbe.

[34]  Grace X. Y. Zheng,et al.  Massively parallel digital transcriptional profiling of single cells , 2016, Nature Communications.

[35]  S. Lewin,et al.  CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART , 2016, PLoS pathogens.

[36]  Jerome H. Kim,et al.  Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand. , 2016, The New England journal of medicine.

[37]  Amalio Telenti,et al.  Guanylate Binding Protein (GBP) 5 Is an Interferon-Inducible Inhibitor of HIV-1 Infectivity. , 2016, Cell host & microbe.

[38]  B. Walker,et al.  Innate Lymphoid Cells Are Depleted Irreversibly during Acute HIV-1 Infection in the Absence of Viral Suppression. , 2016, Immunity.

[39]  K. Shekhar,et al.  Magnitude and Kinetics of CD8+ T Cell Activation during Hyperacute HIV Infection Impact Viral Set Point. , 2015, Immunity.

[40]  P. Linsley,et al.  MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data , 2015, Genome Biology.

[41]  Allon M. Klein,et al.  Droplet Barcoding for Single-Cell Transcriptomics Applied to Embryonic Stem Cells , 2015, Cell.

[42]  Evan Z. Macosko,et al.  Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets , 2015, Cell.

[43]  Jerome H. Kim,et al.  Impact of nucleic acid testing relative to antigen/antibody combination immunoassay on the detection of acute HIV infection , 2015, AIDS.

[44]  Mihai Albu,et al.  C2H2 zinc finger proteins greatly expand the human regulatory lexicon , 2015, Nature Biotechnology.

[45]  Jintanat Ananworanich,et al.  Cross-Clade Ultrasensitive PCR-Based Assays To Measure HIV Persistence in Large-Cohort Studies , 2014, Journal of Virology.

[46]  H. Ding,et al.  Relative resistance of HIV-1 founder viruses to control by interferon-alpha , 2013, Retrovirology.

[47]  L. Picker,et al.  CD4+ T‐cell depletion in HIV infection: mechanisms of immunological failure , 2013, Immunological reviews.

[48]  Jerome H. Kim,et al.  A novel acute HIV infection staging system based on 4th generation immunoassay , 2013, Retrovirology.

[49]  A. Shiau,et al.  Prothymosin α overexpression contributes to the development of pulmonary emphysema , 2013, Nature Communications.

[50]  Feng Gao,et al.  Phenotypic properties of transmitted founder HIV-1 , 2013, Proceedings of the National Academy of Sciences.

[51]  Michael Emerman,et al.  Evolutionary conflicts between viruses and restriction factors shape immunity , 2012, Nature Reviews Immunology.

[52]  M. Malim,et al.  HIV Restriction Factors and Mechanisms of Evasion. , 2012, Cold Spring Harbor perspectives in medicine.

[53]  A. Haase,et al.  Host Genes Associated with HIV-1 Replication in Lymphatic Tissue , 2010, The Journal of Immunology.

[54]  Tracy R. Keeney,et al.  Aptamer-based multiplexed proteomic technology for biomarker discovery , 2010, PloS one.

[55]  G. Gusella,et al.  Prothymosin-α inhibits HIV-1 via Toll-like receptor 4-mediated type I interferon induction , 2010, Proceedings of the National Academy of Sciences.

[56]  H. Ueda,et al.  Stress-induced non-vesicular release of prothymosin-α initiated by an interaction with S100A13, and its blockade by caspase-3 cleavage , 2010, Cell Death and Differentiation.

[57]  Persephone Borrow,et al.  The immune response during acute HIV-1 infection: clues for vaccine development , 2009, Nature Reviews Immunology.

[58]  G. Learn,et al.  Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. , 2009, Cell host & microbe.

[59]  A. Perelson,et al.  Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection , 2009, The Journal of experimental medicine.

[60]  Mila Lebedeva,et al.  Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections , 2009, Journal of Virology.

[61]  Marc C. Johnson,et al.  The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. , 2008, Cell host & microbe.

[62]  M. Simm,et al.  The critical role of human transcriptional repressor CTCF mRNA up-regulation in the induction of anti-HIV-1 responses in CD4(+) T cells. , 2008, Immunology letters.

[63]  P. Bieniasz,et al.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu , 2008, Nature.

[64]  J. Shabanowitz,et al.  Novel Function of Prothymosin Alpha as a Potent Inhibitor of Human Immunodeficiency Virus Type 1 Gene Expression in Primary Macrophages , 2006, Journal of Virology.

[65]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[66]  Michael P Busch,et al.  Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection , 2003, AIDS.

[67]  M. Malim,et al.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein , 2002, Nature.

[68]  Zoe Karetsou,et al.  Prothymosin alpha modulates the interaction of histone H1 with chromatin , 1998, Nucleic Acids Res..

[69]  B. Chesebro,et al.  Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.

[70]  J. Konvalinka,et al.  An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity , 1995, Journal of virology.

[71]  A. Finzi,et al.  Role of CD4 receptor down-regulation during HIV-1 infection. , 2004, Current HIV research.

[72]  J. Kofron,et al.  Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. , 2003, Science.

[73]  rquez,et al.  Prothymosin α is a chromatin-remodelling protein in mammalian cells , 1998 .

[74]  S. Grelli,et al.  Combination treatment with zidovudine, thymosin α1 and interferon-α in human immunodeficiency virus infectionand interferon-α in human immunodeficiency virus infection , 1994 .

[75]  Sandra Romero-Steiner,et al.  Molecular signatures of antibody responses derived from a systems biology study of five human vaccines , 2022 .